title: CYP2D6 and pharmacogenomics: where does future research need to focus? Part 2: clinical aspects.
authors.affiliation: Division of Clinical Pharmacology, Toxicology & Therapeutic Innovation, Department of Pediatrics, Children's Mercy Kansas City & University of Missouri-Kansas City, 2401 Gillham Rd, Kansas City, MO 64108, USA.
authors.forename: J Steven
authors.initials: JS
authors.lastname: Leeder
authors.forename: Andrea
authors.initials: A
authors.lastname: Gaedigk
mesh_terms: D019389:Cytochrome P-450 CYP2D6 / Q000235:genetics*; D005838:Genotype; D006801:Humans; D010597:Pharmacogenetics
chemical_list: D019389:Cytochrome P-450 CYP2D6
keywords: CPIC; CYP2D6; clinical implementation; cytochrome P450; drug-metabolizing enzymes; genetic variation; pharmacogenetics